Select for export Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/jpm.2022.0036 PubMed 35285721 Copy citation Copy BibTeX Journal of palliative medicine 2022-07-31 Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K PubMed Published psilocybin DepressionAnxietyPTSD Other More
Select for export From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/nmd.0000000000001489 PubMed 35900779 Copy citation Copy BibTeX The Journal of Nervous and Mental Disease 2022-07-31 Suleiman M, Basu A, Belal S, Jacob T. Europe PMC Published psilocybin End-of-Life DistressMicrodosing Other More
Select for export Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.917199 PubMed 35923458 Copy citation Copy BibTeX Unknown journal 2022-07-11 Ko K, Knight G, Rucker JJ, Cleare AJ. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.07.10.22277414 Copy citation Copy BibTeX medRxiv 2022-07-09 Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T medRxiv PREPRINT (not peer reviewed) psilocybin Headache / MigraineBrain ImagingMechanism of Action Clinical Trial More
Select for export Psychedelic drugs for psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jns.2022.120332 PubMed 35841696 Copy citation Copy BibTeX Unknown journal 2022-07-04 da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psychedelic use in India, its pattern and personal significance - findings from an online survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4103/indianjpsychiatry.indianjpsychiatry_447_21 PubMed 36060724 Copy citation Copy BibTeX Indian Journal of Psychiatry 2022-06-30 Gokul Raj OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Psychedelic-inspired approaches for treating neurodegenerative disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/jnc.15544 PubMed 34816433 Copy citation Copy BibTeX Journal of neurochemistry 2022-06-30 Saeger HN, Olson DE PubMed Published psilocybin DepressionPTSDAddiction Other More
Select for export Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2022.927984 PubMed 35837277 Copy citation Copy BibTeX Unknown journal 2022-06-27 Vorobyeva N, Kozlova AA. Europe PMC Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export Associations between classic psychedelics and nicotine dependence in a nationally representative sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-14809-3 PubMed 35732796 Copy citation Copy BibTeX Scientific Reports 2022-06-21 Jones G, Lipson J, Nock MK. Europe PMC Published psilocybin AddictionObservational Study Observational Study More
Select for export How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06106-8 PubMed 35348806 Copy citation Copy BibTeX Psychopharmacology 2022-05-31 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH PubMed Published psilocybin DepressionPharmacologyMystical Experience Other More
Select for export Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits? No abstract availability was recorded for this entry. Details DOI 10.1080/14740338.2022.2063274 PubMed 35387542 Copy citation Copy BibTeX Expert opinion on drug safety 2022-05-31 Husain MI, Umer M, Mulsant BH PubMed Published psilocybin DepressionPTSDAddiction Other More
Select for export New Paradigms of Old Psychedelics in Schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ph15050640 PubMed 35631466 Copy citation Copy BibTeX Unknown journal 2022-05-22 Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-05-19 National Institute of Mental Health, Czech Republic ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s13011-022-00468-0 PubMed 35568884 Copy citation Copy BibTeX Substance Abuse Treatment Prevention and Policy 2022-05-13 Mocanu V, Mackay L, Christie D, Argento E. Europe PMC Published psilocybin AgingSafety Other More
Select for export Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-08085-4 PubMed 35393455 Copy citation Copy BibTeX Scientific Reports 2022-04-06 Jones G, Ricard JA, Lipson J, Nock MK. Europe PMC Published psilocybin AddictionClinical TrialObservational Study Clinical Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Counselors’ attitudes toward psychedelics and their use in therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/jcad.12429 Copy citation Copy BibTeX Journal of Counseling & Development 2022-03-18 Benjamin Hearn, Michael D. Brubaker, George B. Richardson OpenAlex Published psilocybin AddictionReceptor PharmacologyObservational Study Observational Study More
Select for export Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-1321542/v1 Copy citation Copy BibTeX Research Square 2022-03-07 Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionHeadache / MigraineNeuroplasticity Animal Study More
Select for export Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06092-x PubMed 35233648 Copy citation Copy BibTeX Unknown journal 2022-03-01 Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. Europe PMC Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2044096 PubMed 35225726 Copy citation Copy BibTeX Unknown journal 2022-02-27 Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
